4.7 Article

Thiosemicarbazide Derivatives Decrease the ATPase Activity of Staphylococcus aureus Topoisomerase IV, Inhibit Mycobacterial Growth, and Affect Replication in Mycobacterium smegmatis

期刊

出版社

MDPI
DOI: 10.3390/ijms22083881

关键词

thiosemicarbazides; antibacterial agents; molecular modelling; bacterial type IIA topoisomerases; DNA replication; time-lapse microfluidic microscopy

资金

  1. National Science Center, Poland [OPUS 2017/25/B/NZ1/00657, UMO2012/05/D/NZ7/02278, UMO-2013/11/N/NZ7/00765]
  2. University of Lodz [B2011000000038.01]

向作者/读者索取更多资源

Compounds targeting bacterial topoisomerases have been developed as potential antibacterial agents. Studies have shown that small-molecular weight thiosemicarbazides can act as gyrase and topoisomerase IV inhibitors. These compounds reduce the ATP hydrolysis ability of the ParE subunit of Staphylococcus aureus topoisomerase IV and exhibit better antibacterial activity against clinical strains of S. aureus. Additionally, compound 7 has been shown to prolong the replication process duration in Mycobacterium smegmatis and induce growth arrest of bacterial cells, making it a potential novel group of bacterial topoisomerase inhibitors.
Compounds targeting bacterial topoisomerases are of interest for the development of antibacterial agents. Our previous studies culminated in the synthesis and characterization of small-molecular weight thiosemicarbazides as the initial prototypes of a novel class of gyrase and topoisomerase IV inhibitors. To expand these findings with further details on the mode of action of the most potent compounds, enzymatic studies combined with a molecular docking approach were carried out, the results of which are presented herein. The biochemical assay for 1-(indol-2-oyl)-4-(4-nitrophenyl) thiosemicarbazide (4) and 4-benzoyl-1-(indol-2-oyl) thiosemicarbazide (7), showing strong inhibitory activity against Staphylococcus aureus topoisomerase IV, confirmed that these compounds reduce the ability of the ParE subunit to hydrolyze ATP rather than act by stabilizing the cleavage complex. Compound 7 showed better antibacterial activity than compound 4 against clinical strains of S. aureus and representatives of the Mycobacterium genus. In vivo studies using time-lapse microfluidic microscopy, which allowed for the monitoring of fluorescently labelled replisomes, revealed that compound 7 caused an extension of the replication process duration in Mycobacterium smegmatis, as well as the growth arrest of bacterial cells. Despite some similarities to the mechanism of action of novobiocin, these compounds show additional, unique properties, and can thus be considered a novel group of inhibitors of the ATPase activity of bacterial type IIA topoisomerases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据